Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ryan

Showing results (151-160 of 236) with videos related to

Pageof 24
Sort By:
Progress in Clinical and Biological Research|January 1, 1986
New directions in antihypertensive drug therapyH R Kaplan, D M Cohen, D B Evans, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 26, 2001
Hematological effects in F344 rats and B6C3F1 mice during the 13-week gavage toxicity study of methylene blue trihydrateM R Hejtmancik, M J Ryan, J D Toft, et al.
The Journal of Antibiotics|October 1, 1987
Direct selection of a specifically blocked mutant of Actinomadura brunnea. Isolation of a third 8-methoxy substituted chlortetracyclineE B Smith, H K Munayyer, M J Ryan, et al.
Medical and Pediatric Oncology|January 1, 1978
CCNU, vinblastine, and delalutin therapy in renal cell carcinomaG J Vosika, M J Ryan, I A Fortuny, et al.
The Science of the Total Environment|November 27, 2012
Biotic interactions in temporal trends (1992-2010) of organochlorine contaminants in the aquatic food web of Lake Laberge, Yukon TerritoryM J Ryan, G A Stern, K A Kidd, et al.
Biopharmaceutics & Drug Disposition|May 7, 1998
Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeysJ A Cook, P J Burger, B M Michniewicz, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1993
Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerationsR K Palmer, S T Rapundalo, B L Batley, et al.
Kidney International|June 26, 2001
Risk factors and mortality associated with calciphylaxis in end-stage renal diseaseA R Mazhar, R J Johnson, D Gillen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeysM J Ryan, G W Hicks, B L Batley, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 7, 2002
Comparative gavage subchronic toxicity studies of o-chloroaniline and m-chloroaniline in F344 rats and B6C3F1 miceM R Hejtmancik, B A Trela, P J Kurtz, et al.
Pageof 24

Showing results (151-160 of 236) with videos related to

Sort By:
Pageof 24
Progress in Clinical and Biological Research|January 1, 1986
New directions in antihypertensive drug therapyH R Kaplan, D M Cohen, D B Evans, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 26, 2001
Hematological effects in F344 rats and B6C3F1 mice during the 13-week gavage toxicity study of methylene blue trihydrateM R Hejtmancik, M J Ryan, J D Toft, et al.
The Journal of Antibiotics|October 1, 1987
Direct selection of a specifically blocked mutant of Actinomadura brunnea. Isolation of a third 8-methoxy substituted chlortetracyclineE B Smith, H K Munayyer, M J Ryan, et al.
Medical and Pediatric Oncology|January 1, 1978
CCNU, vinblastine, and delalutin therapy in renal cell carcinomaG J Vosika, M J Ryan, I A Fortuny, et al.
The Science of the Total Environment|November 27, 2012
Biotic interactions in temporal trends (1992-2010) of organochlorine contaminants in the aquatic food web of Lake Laberge, Yukon TerritoryM J Ryan, G A Stern, K A Kidd, et al.
Biopharmaceutics & Drug Disposition|May 7, 1998
Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeysJ A Cook, P J Burger, B M Michniewicz, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1993
Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerationsR K Palmer, S T Rapundalo, B L Batley, et al.
Kidney International|June 26, 2001
Risk factors and mortality associated with calciphylaxis in end-stage renal diseaseA R Mazhar, R J Johnson, D Gillen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeysM J Ryan, G W Hicks, B L Batley, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 7, 2002
Comparative gavage subchronic toxicity studies of o-chloroaniline and m-chloroaniline in F344 rats and B6C3F1 miceM R Hejtmancik, B A Trela, P J Kurtz, et al.
Pageof 24